Viking Therapeutics (NASDAQ: VKTX) and Summit Therapeutics (NASDAQ: SMMT). Both saw their shares more than double in 2024, ...
Let's find out. Viking Therapeutics' leading candidate, VK2735, is a potential GLP-1 weight loss medicine. It reported excellent results in a phase 2 study. The company also has an oral ...
Get ready for a thrilling journey back in time! The White Hart Renaissance Faire is introducing an exciting new event—the Valhalla Blooms Faire, a Viking Spring Festival, […] ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results